Abstract
A series of novel indazole derivatives have been designed and synthesized by a novel method and evaluated for their antibacterial activity. The compounds were designed to study their interactions as inhibitor of DNA gyrase B. Salicylaldehyde and hydrazine hydrate have been refluxed along with polyethylene glycol and catalytic amount of ptoluenesulfonic acid to yield desired compounds. All the synthesized compounds were subjected to in vitro anti-bacterial activity studies against B. Subtilis, S. aureus, E. coli, P. Aeruiginosa and S. typhi. Substituted compounds I5, I9 and I13 exhibited significant inhibition of bacterial growth. The MIC value of these 3 compounds was found to be 50µg/mL. Compounds substituted at 5th and 6th position of indazole were found to show better hydrogen bond interactions with DNA gyrase B and appreciable potential for anti-bacterial activity. They can be used as potential molecule in bacterial resistance cases. The present studies will be useful for designing selective compounds for inhibition of DNA gyrase B.
Keywords: Hydrazine hydrate, minimum inhibitory concentration, polyethylene glycol, p-toluenesulfonic acid, salicylaldehyde.
Current Bioactive Compounds
Title:Design, Synthesis and Evaluation of Antibacterial Activity of Novel Indazole Derivatives
Volume: 9 Issue: 4
Author(s): Anuruddha Chabukswar, Bhanudas Kuchekar, Pradeep Lokhande, Mangesh Tryambake, Bharat Pagare, Vinayak Kadam, Swati Jagdale and Vasant Chabukswar
Affiliation:
Keywords: Hydrazine hydrate, minimum inhibitory concentration, polyethylene glycol, p-toluenesulfonic acid, salicylaldehyde.
Abstract: A series of novel indazole derivatives have been designed and synthesized by a novel method and evaluated for their antibacterial activity. The compounds were designed to study their interactions as inhibitor of DNA gyrase B. Salicylaldehyde and hydrazine hydrate have been refluxed along with polyethylene glycol and catalytic amount of ptoluenesulfonic acid to yield desired compounds. All the synthesized compounds were subjected to in vitro anti-bacterial activity studies against B. Subtilis, S. aureus, E. coli, P. Aeruiginosa and S. typhi. Substituted compounds I5, I9 and I13 exhibited significant inhibition of bacterial growth. The MIC value of these 3 compounds was found to be 50µg/mL. Compounds substituted at 5th and 6th position of indazole were found to show better hydrogen bond interactions with DNA gyrase B and appreciable potential for anti-bacterial activity. They can be used as potential molecule in bacterial resistance cases. The present studies will be useful for designing selective compounds for inhibition of DNA gyrase B.
Export Options
About this article
Cite this article as:
Chabukswar Anuruddha, Kuchekar Bhanudas, Lokhande Pradeep, Tryambake Mangesh, Pagare Bharat, Kadam Vinayak, Jagdale Swati and Chabukswar Vasant, Design, Synthesis and Evaluation of Antibacterial Activity of Novel Indazole Derivatives, Current Bioactive Compounds 2013; 9 (4) . https://dx.doi.org/10.2174/1573407209999131231095550
DOI https://dx.doi.org/10.2174/1573407209999131231095550 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability
Anti-Cancer Agents in Medicinal Chemistry Coumarinyl Aryl/Alkyl Sulfonates with Dual Potential: Alkaline Phosphatase and ROS Inhibitory Activities: In-Silico Molecular Modeling and ADME Evaluation
Letters in Drug Design & Discovery Bladder Cancer: Innovative Approaches Beyond the Diagnosis
Current Medicinal Chemistry Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method
Current Pharmaceutical Analysis Discovery Strategies in a BioPharmaceutical Startup: Maximising your Chances of Success Using Computational Filters
Current Pharmaceutical Design subject Index To Volume 5
Combinatorial Chemistry & High Throughput Screening Review of Endocrine Manifestations of Antiphospholid Syndrome
Current Rheumatology Reviews Src Family Kinases as Potential Therapeutic Targets for Malignancies and Immunological Disorders
Current Medicinal Chemistry Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization
Current Organic Chemistry Transdermal Anti-inflammatory Delivery for Solid Lipid Nanoparticles of Ketoprofen by Microwave-assisted Microemulsion
Recent Advances in Inflammation & Allergy Drug Discovery New Insights into the Regulation of Liver Inflammation and Oxidative Stress
Mini-Reviews in Medicinal Chemistry Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Can Chest Computed Tomography Findings of Symptomatic COVID-19 Patients Upon Admission Indicate Disease Prognosis and Clinical Outcome?
Current Medical Imaging Molecular Docking, ADMET Analysis and Molecular Dynamics (MD) Simulation to Identify Synthetic Isoquinolines as Potential Inhibitors of SARS-CoV-2 M<sup>PRO</sup>
Current Computer-Aided Drug Design SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Current Medicinal Chemistry GABAA/Bz Receptor Subtypes as Targets for Selective Drugs
Current Medicinal Chemistry Brain Angiotensin and Cardiovascular Reactivity to Negative and Positive Emotional Stress
Current Hypertension Reviews Chalcones and <i>Bis</i>-Chalcones Analogs as DPPH and ABTS Radical Scavengers
Letters in Drug Design & Discovery 1,3,5-Triazine Analogs: A Potent Anticancer Scaffold
Current Signal Transduction Therapy Biomarkers For the Diagnosis of Depression: Recent Updates
Current Psychiatry Research and Reviews